Please use this identifier to cite or link to this item: http://hdl.handle.net/10553/113189
Title: Metabolomics of the tryptophan-kynurenine degradation pathway and risk of atrial fibrillation and heart failure: potential modification effect of Mediterranean diet
Authors: Razquin, Cristina
Ruiz-Canela, Miguel
Toledo, Estefania
Hernández-Alonso, Pablo
Clish, Clary B.
Guasch-Ferré, Marta
Li, Jun
Wittenbecher, Clemens
Dennis, Courtney
Alonso-Gómez, Angel
Fitó, Montse
Liang, Liming
Corella, Dolores
Gómez-Gracia, Enrique
Estruch, Ramon
Fiol, Miquel
Lapetra, Jose
Serra Majem, Luis 
Ros, Emilio
Aros, Fernando
Salas-Salvadó, Jordi
Hu, Frank B.
Martínez-González, Miguel A.
UNESCO Clasification: 32 Ciencias médicas
3206 Ciencias de la nutrición
Keywords: Atrial Fibrillation
Case–Control
Heart Failure
Kynurenine
Mediterranean Diet, et al
Issue Date: 2021
Journal: The American journal of clinical nutrition 
Abstract: BACKGROUND: The tryptophan-kynurenine pathway is linked to inflammation. We hypothesize that metabolites implicated in this pathway may be associated with the risk of heart failure (HF) or atrial fibrillation (AF) in a population at high risk of cardiovascular disease. OBJECTIVES: We aimed to prospectively analyze the associations of kynurenine-related metabolites with the risk of HF and AF and to analyze a potential effect modification by the randomized interventions of the PREDIMED (Prevención con Dieta Mediterránea) trial with Mediterranean diet (MedDiet). METHODS: Two case-control studies nested within the PREDIMED trial were designed. We selected 324 incident HF cases and 502 incident AF cases individually matched with ≤3 controls. Conditional logistic regression models were fitted. Interactions with the intervention were tested for each of the baseline plasma metabolites measured by LC-tandem MS. RESULTS: Higher baseline kynurenine:tryptophan ratio (OR for 1 SD: 1.20; 95% CI: 1.01, 1.43) and higher levels of kynurenic acid (OR: 1.19; 95% CI: 1.01, 1.40) were associated with HF. Quinolinic acid was associated with AF (OR: 1.15; 95% CI: 1.01, 1.32) and HF (OR: 1.25; 95% CI: 1.04, 1.49). The MedDiet intervention modified the positive associations of kynurenine (Pinteraction = 0.006), kynurenic acid (Pinteraction = 0.008), and quinolinic acid (Pinteraction = 0.033) with HF and the association between kynurenic acid and AF (Pinteraction = 0.02). CONCLUSIONS: We found that tryptophan-kynurenine pathway metabolites were prospectively associated with higher HF risk and to a lesser extent with AF risk. Moreover, an effect modification by MedDiet was observed for the association between plasma baseline kynurenine-related metabolites and the risk of HF, showing that the positive association of increased levels of these metabolites and HF was restricted to the control group.
URI: http://hdl.handle.net/10553/113189
DOI: 10.1093/ajcn/nqab238
Source: The American journal of clinical nutrition[EISSN 1938-3207],v. 114 (5), p. 1646-1654, (Noviembre 2021)
Appears in Collections:Artículos
Show full item record

Google ScholarTM

Check

Altmetric


Share



Export metadata



Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.